On October 10, 2024, the FDA approved Accord BioPharma’s Imuldosa™ (ustekinumab-srlf), the fifth biosimilar of Janssen / Johnson & Johnson’s Stelara®…
Read More →According to the United States Bureau of Labor Statistics, a reported 419,000 private-sector employees in California sustained workplace injuries and…
Read More →The FDA has granted approval for Novocure‘s wearable medical device, Optune Lua, designed to treat advanced non-small cell lung cancer (NSCLC). The…
Read More →Jurisdiction: Supreme Court of New York, New York County – In a New York City asbestos action, defendant Tishman Liquidating…
Read More →On October 16, 2024, Birth Choice of San Marcos (“BirthChoice”) filed a notice of data breach with the Attorney General…
Read More →In a disappointing, yet somewhat unsurprising, turn of events, the Consumer Product Safety Commission (CPSC) has refused to retract Commissioner…
Read More →Additional and clarified data compliance obligations will soon come into force under the long-awaited Network Data Security Management Regulation (“Regulation“),…
Read More →On October 11, 2024, Judge Orelia E. Merchant issued a decision construing the claims of three asserted patents in a…
Read More →It is often said that the law lags behind the pace of technological development. Yet, while computer chip implants and…
Read More →Morrison Foerster Investigations + White Collar Defense partner Nate Mendell, former Acting U.S. Attorney for the District of Massachusetts, hosted…
Read More →